Form 4 for CRL Charles River Laboratories
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-16 · accession 0001127602-24-005822 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | 2024-02-16 | CRL | FOSTER JAMES C | COB, Pres, CEO, Dir | G - Gift | $0.00 | -4,000 | 224.6K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-16 | G | D | 4,000 | $0.00 | 224,613 | D | — | — |